Enlivex
ENLVInstitutional ownership · Q4 2022
Latest quarter (Q2 2026)
Institutional holders
21
+3 (+16.7%) vs Q3 2022
Reported value
$1.3M
-6.9% vs Q3 2022
Shares held
338.0K
+4.6K shares
Quarter
Q4 2022
Period ended Dec 31, 2022
21 institutional managers reported holding 337,958 shares worth $1,315,936 on Form 13F for Q4 2022, against 18 in Q3 2022. Share positions on CUSIP M4130Y171 only; option legs and principal-amount lines are not counted.
Top 21 institutional holders · Q4 2022
| # | Manager | Shares | Value | % of portfolio | Change | Position page |
|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 59,532 | $232.2K | < 0.01% | +20.0K | Position |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 54,189 | $213.0K | < 0.01% | -4.7K | Position |
| 3 | Compagnie Lombard Odier SCmA | 50,000 | $190.0K | < 0.01% | — | Position |
| 4 | MORGAN STANLEY | 40,726 | $160.4K | < 0.01% | -3.8K | Position |
| 5 | UBS Group AG | 33,445 | $131.8K | < 0.01% | +1.6K | Position |
| 6 | The Goldman Sachs Group Inc | 18,908 | $74.5K | < 0.01% | -1.8K | Position |
| 7 | Susquehanna International Group Ltd | 18,887 | $72.1K | 0.03% | -1.4K | Position |
| 8 | GROUP ONE TRADING L P | 13,499 | $52.6K | < 0.01% | +13.0K | Position |
| 9 | EDMOND DE ROTHSCHILD HOLDING S A | 13,000 | $50.7K | < 0.01% | — | Position |
| 10 | WELLS FARGO & COMPANY MN | 11,746 | $46.3K | < 0.01% | -6.3K | Position |
| 11 | GEODE CAPITAL MANAGEMENT LLC | 10,420 | $40.0K | < 0.01% | — | Position |
| 12 | SIMPLEX TRADING LLC | 8,153 | $31.0K | < 0.01% | +3.0K | Position |
| 13 | Steward Partners Investment Advisory LLC | 3,000 | $11.8K | < 0.01% | — | Position |
| 14 | Barclays PLC | 1,000 | $3.9K | < 0.01% | — | Position |
| 15 | Bank of America Corporation | 647 | $2.5K | < 0.01% | +147 | Position |
| 16 | ADVISOR GROUP HOLDINGS INC | 400 | $2.0K | < 0.01% | — | Position |
| 17 | Red Tortoise LLC | 150 | $591 | < 0.01% | New | Position |
| 18 | EWG Elevate Inc | 100 | $394 | < 0.01% | New | Position |
| 19 | Advisory Services Network LLC | 43 | $168 | < 0.01% | New | Position |
| 20 | Sargent Bickham Lagudis LLC | 15 | $59 | < 0.01% | New | Position |
| 21 | JPMorgan Chase & Co | 98 | $0 | 0 | New | Position |
Values as reported on each manager's Q4 2022 Form 13F. Change is in shares against the manager's prior-quarter filing.
13F holders by quarter
| Quarter | Holders | Shares | Value |
|---|---|---|---|
| Q2 2026 | 24 -10 | 4.2M | $2.3M |
| Q1 2026 | 34 +9 | 3.6M | $3.4M |
| Q4 2025 | 25 -3 | 1.3M | $929.4K |
| Q3 2025 | 28 +7 | 914.5K | $950.2K |
| Q2 2025 | 21 -4 | 2.6M | $2.9M |
| Q1 2025 | 25 +1 | 3.2M | $3.1M |
| Q4 2024 | 24 +5 | 3.4M | $4.0M |
| Q3 2024 | 19 +3 | 2.6M | $4.3M |
| Q2 2024 | 16 +1 | 2.1M | $3.0M |
| Q1 2024 | 15 -2 | 326.1K | $1.2M |
| Q4 2023 | 17 +1 | 188.5K | $509.2K |
| Q3 2023 | 16 -3 | 257.6K | $408.4K |
| Q2 2023 | 19 | 302.5K | $795.1K |
| Q1 2023 | 19 -2 | 343.3K | $1.2M |
| Q4 2022 | 21 +3 | 338.0K | $1.3M |
| Q3 2022 | 18 -2 | 333.4K | $1.4M |
| Q2 2022 | 20 -5 | 604.4K | $2.9M |
| Q1 2022 | 25 +2 | 846.3K | $4.8M |
| Q4 2021 | 23 +4 | 662.7K | $4.1M |
| Q3 2021 | 19 | 847.7K | $8.4M |
Q3 2021–Q2 2026, as reported on Form 13F. Earlier quarters are in the ownership explorer below.
Across other SEC filings
5%+ holders · 13D/G
1 filer| Filer | % of class | Filed |
|---|---|---|
| Lind Global Asset Management XIV LLC 13G | 10.0% | 2026-08-13 |
Latest Schedule 13D or 13G from each filer naming this CUSIP; stakes a filer has reported closed are left out.
Ownership explorer
Loading ownership explorer…
Security Details
| CUSIP | M4130Y171 |
|---|---|
| Symbol | ENLV |
| Type | Common stock |
| Class | COM as filed on 13F |
| Company | Enlivex |
Other securities from this issuer
| Name | Symbol | CUSIP | Type |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD | ENLV | M4130Y106 | Common stock |
Identifier History
| Type | Value | From | To |
|---|---|---|---|
| CUSIP | M4130Y171 | 2026-07-15 | Current |
Listing History
| Symbol | Exchange | From | To |
|---|---|---|---|
| ENLV | US | 2026-07-15 | Current |